Evaluating the effects of amantadin, modafinil and acetyl-l-carnitine on fatigue in multiple sclerosis - Result of a pilot randomized, blind study

Clinical Neurology and Neurosurgery

Volumn 115, Issue SUPPL.1, 2013, Pages

  Ledinek, Alenka Horvat ^a   Sajko, Mojca Cizek ^b   Rot, Uros ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Acetyl l carnitine; Amantadine; Fatigue; Modafinil; Multiple sclerosis

Indexed keywords

AMANTADINE; LEVACECARNINE; METHYLPREDNISOLONE; MODAFINIL; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; DISABILITY SEVERITY; DISEASE DURATION; DRUG EFFICACY; DRUG SCREENING; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FATIGUE IMPACT SCALE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NAUSEA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SHORT FORM 36; SINGLE BLIND PROCEDURE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ACETYL-L-CARNITINE; AMANTADINE; FATIGUE; MODAFINIL; MULTIPLE SCLEROSIS;

ACETYLCARNITINE; ADULT; AMANTADINE; BENZHYDRYL COMPOUNDS; DRUG COMBINATIONS; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 84890054444     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2013.09.029     Document Type: Article

References (29)

1. B.G. Weinshenker The natural history of multiple sclerosis Neurol Clin 13 1995 119 145
2. R.T. Shapiro Symptom management in multiple sclerosis Ann Neurol 36 1994 123 129
3. L.B. Krupp, L.A. Alvarez, and N.G. La Rocca Clinical characteristic of fatigue in multiple sclerosis Arch Neurol 45 1988 435 437
4. P. Flachenecker Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment Mult Scler 14 2008 274 277
5. T.J. Bradley Fatigue in multiple sclerosis: mechanisms evaluating and treatment Sleep 9 2010 219 227
6. V. Janardhan Quality of life in patients with multiple sclerosis: the impact of fatigue and depression J Neurol Sci 205 2002 51 58
7. S. Pittion-Vouyovitch Fatigue in multiple sclerosis is related to disability, depression and quality of life J Neurol Sci 243 2006 39 45
8. Fatigue Guidelines Panel of Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence based management strategies for fatigue in multiple sclerosis 1998 Paralyzed Veterans of America Washington, DC
9. The Canadian MS Research Group A randomized controlled trial of amantadin in fatigue in multiple sclerosis Can J Neurol Sci 14 1987 273 278
10. R.A. Cohen Amantadine treatment of fatigue associated with multiple sclerosis Arch Neurol 46 1989 676 680
11. G.A. Rosenberg Amatadine, fatigue and multiple sclerosis Arch Neurol 45 1988 1104 1106
12. E. Pucci Amantadine fot fatigue in multiple sclerosis Cochrane Database Syst Rev 2007 Issue 1. Art. No.:CD002818. DOI:10. 10002/14651858.CD002818
13. L.B. Krupp Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadin, pemolin, and placebo Neurology 45 1995 1956 1961
14. K.W. Rammohan Efficacy and safety of modafinil for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study J Neurol Neurosurg Psychiatry 72 2002 179 183
15. U.A. Zifko Modafinil in treatment of fatigue in multiple sclerosis. Results open label study J Neurol 249 2002 983 987
16. B. Stankoff Modafinil for fatigue in MS. A randomized placebo controlled double blind study Neurology 64 2005 1139 1143
17. F. Möller HAGIL (Hamburg Vigil study): a randomized placebo controlled double blind study with modafinil for treatment of fatigue in patients with multiple sclerosis Mult Scler J 8 2010 1002 1009
18. V. Tomassini Comparison of the effects of acetyl-l-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results a pilot, randomised, double-blind crossover trial J Neurol Sci 218 2004 103 118
19. A.V. Plioplys Amantadine and l-carnitine treatment of chronic fatigue syndrome Neuropsychobiology 35 1997 16 23
20. C. Leburn Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy induced fatigue Mult Scler 12 2006 321 324
21. J.F. Kurtzke Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS) Neurology 33 1983 1444 1452
22. D. Kos Evaluation of the modified fatigue impact scale in four different European countries Mult Scler 11 2005 76 80
23. P. Flachenecker Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters Mult Scler 8 2002 523 526
24. O. Hadjimichael Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey Health and Quality of Life Outcome 6 2008 100 111
25. B.R. Staton Sleep and fatigue in multiple sclerosis Mult Scler 12 2006 481 486
26. H. Kaynak Fatigue and sleep disturbance in multiple sclerosis Eur J Neurol 13 2006 1333 1339
27. H.P. Attarian The relationship of sleep disturbance and fatigue in multiple sclerosis Arch Neurol 61 2004 525 528
28. J. Riazi Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles J Neurol Neurosurg Psychiatry 74 2003 710 714
29. S. Merkelbach Is there a differential impact on fatigue and physical disability on quality of life in multiple sclerosis? J Nerv Ment Dis 190 2002 383 388